Royalty Pharma plc
RPRX
Pozycja w akcjach
#875
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Cena akcji
$61.87
Kapitalizacja rynkowa
$27.55B
Zmiana (1 dzień)
2.65%
Zmiana (1 rok)
68.91%
Kraj
US
Handel Royalty Pharma plc (RPRX)
Kategoria
Healthcare
Wskaźnik P/S dla Royalty Pharma plc (RPRX)
Wskaźnik P/S na dzień October 2026 TTM: 10.31
Według najnowszych raportów finansowych i ceny akcji Royalty Pharma plc, obecny wskaźnik P/S (TTM) wynosi 10.31. Na koniec 2023 wynosił 5.34.
Historia wskaźnika P/S dla Royalty Pharma plc od 2015 do 2026
Wskaźnik P/S na koniec każdego roku
| Rok | Wskaźnik P/S | Zmień |
|---|---|---|
| 2026 (TTM) | 10.31 | 104.99% |
| 2024 | 5.03 | -5.87% |
| 2023 | 5.34 | -30.98% |
| 2022 | 7.74 | 7.16% |
| 2021 | 7.22 | -21.12% |
| 2020 | 9.15 | 5.36% |
| 2019 | 8.69 | -1.07% |
| 2018 | 8.78 | -10.97% |
| 2017 | 9.86 | -31.45% |
| 2016 | 14.39 | -11.98% |
| 2015 | 16.35 | 0.00% |
Wskaźnik P/S dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/S | Różnica wskaźnika P/S | Kraj |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 15.12 | 46.67% |
US
|
|
| 2.36 | -77.11% |
HK
|
